Atlas Trials

Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

Clinical trial NCT06753994 · RECRUITING

Trial details

NCT number
NCT06753994
Sponsor
McGill University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
DiabetesType1diabetesT1D
Start date
2024-12-05
Primary completion
2027-01-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.